Botulinum neurotoxins for use in therapy
AssigneeBonti, Inc.
InventorsSawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
Claims40
A method for performing a cosmetic treatment, comprising administering a therapeutically effective amount comprising between about 4 and 40 picograms/kg of a fast-acting neurotoxin to a patient in the area where treatment is desired.
A method for modifying a previous cosmetic treatment, comprising administering a therapeutically effective amount comprising between about 4 and 40 picograms/kg of a fast-acting neurotoxin to a patient in the proximity of an area that was previously subject to a cosmetic treatment.
(canceled)
A method for administrating a therapeutically effective amount of a neurotoxin to a patient, wherein said neurotoxin dosage is expressed in nanograms (ng).
A method for modifying a previous neurotoxin treatment, comprising administering not more than 10 ng of a fast-acting neurotoxin to a patient in the proximity of an area that was previously subject to a neurotoxin treatment.
A method for minimizing scarring, comprising administering a therapeutically effective amount comprising between about 4 and 40 picograms/kg of a short-acting neurotoxin to a patient in the proximity of a wound.
Dependencies are inferred from the claim text.